Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Apetoh, Lionel, Ghiringhelli, François, Tesniere, Antoine, Obeid, Michel, Ortiz, Carla, Criollo, Alfredo, Mignot, Grégoire, Maiuri, M Chiara +20 more·2007·Nature Medicine

DOI 10.1038/nm1622

Cited by (1,010)

Items 401–500 of 1,010

Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling
A Ko, A Kanehisa, Isabelle Martins, Laura Senovilla, Cyrus Chargari, Delphine Dugué, Guillermo Mariño, Oliver Kepp, Mickaël Michaud, Jean‐Luc Perfettini et al. · 2013 · Cell Death and Differentiation
The role of tumor-associated macrophages in breast cancer progression
Elias I. Obeid, Rita Nanda, Yang‐Xin Fu, Olufunmilayo Ibironke Olopade · 2013 · International Journal of Oncology
Immunogenic cell death modalities and their impact on cancer treatment
Oliver Kepp, Antoine Tesnière, Frédéric Schlemmer, Mickaël Michaud, Laura Senovilla, Laurence Zitvogel, Guido Kroemer · 2009 · APOPTOSIS
Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
Gao, Jing, Wang, Wei-qi, Pei, Qing, Lord, Megan S., Yu, Hai-jun · 2020 · Acta Pharmacologica Sinica
Radiotherapy, immunity, and immune checkpoint inhibitors
Connor M. Lynch, Sean P. Pitroda, Ralph R. Weichselbaum · 2024 · The Lancet Oncology
Natural Killer Cell IFN-γ Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor–Bearing Patients
Ménard, Cédric, Blay, Jean-Yves, Borg, Christophe, Michiels, Stefan, Ghiringhelli, François, Robert, Caroline, Nonn, Céline, Chaput, Nathalie, Taïeb, Julien, Delahaye, Nicolas F. et al. · 2009 · Cancer Research
Radiation, Inflammation, and Immune Responses in Cancer
Gabriele Multhoff, Jürgen Radons · 2012 · Frontiers in Oncology
The multifaceted role of autophagy in cancer and the microenvironment
Hendrik Folkerts, Susan Hilgendorf, Edo Vellenga, Edwin Bremer, Valerie R. Wiersma · 2018 · Medicinal Research Reviews
Nanomaterial-Based Tumor Photothermal Immunotherapy
Peng Xu, Feng Liang · 2020 · International Journal of Nanomedicine
Ecto‐calreticulin in immunogenic chemotherapy
Obeid, Michel, Tesniere, Antoine, Panaretakis, Theocharis, Tufi, Roberta, Joza, Nick, Van Endert, Peter, Ghiringhelli, François, Apetoh, Lionel, Chaput, Nathalie, Flament, Caroline et al. · 2007 · Immunological Reviews
Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
Adkins, Irena, Fucikova, Jitka, Garg, Abhishek D, Agostinis, Patrizia, Špíšek, Radek · 2014 · OncoImmunology
Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin–Yang interplay between inflammation and cancer
Silvio Danese, Alberto Mantovani · 2010 · Oncogene
Calreticulin Expression in Human Non–Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis
Jitka Palich Fucikova, Étienne Becht, Kristina Iribarren, Jérémy Goc, Romain Remark, Diane Damotte, Marco Alifano, Priyanka Devi-Marulkar, Jérôme Biton, Claire Germain et al. · 2016 · Cancer Research
Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer
Alessandro Leonetti, Birgit M. M. Wever, Giulia Mazzaschi, Yehuda G. Assaraf, Christian Diego Rolfo, Federico Quaini, Marcello Tiseo, Elisa Giovannetti · 2019 · Drug Resistance Updates
A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple‐negative breast cancer
Alice Y. Ho, Christopher Andrew Barker, Brittany B. Arnold, Simon N. Powell, Zishuo I. Hu, Ayca Gucalp, Lizza Lebron‐Zapata, Hannah Yong Wen, Cindy E. Kallman, Alessandro D’Agnolo et al. · 2019 · Cancer
Novel Subset of CD8α+ Dendritic Cells Localized in the Marginal Zone Is Responsible for Tolerance to Cell-Associated Antigens
Chun‐Hong Qiu, Yasunobu Miyake, Hitomi Kaise, Hiroshi Kitamura, Osamu Ohara, Masato Tanaka · 2009 · The Journal of Immunology
Langerhans Cells: Sensing the Environment in Health and Disease
Julie Deckers, Hamida Hammad, Esther Hoste · 2018 · Frontiers in Immunology
Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
Alfonso Serrano del Valle, Alberto Anel, Javier Naval, Isabel Marzo · 2019 · Frontiers in Cell and Developmental Biology
Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells
Uhl, M, Kepp, O, Jusforgues-Saklani, H, Vicencio, J-M, Kroemer, G, Albert, M L · 2009 · Cell Death & Differentiation
Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences
Nikko Brix, Anna Tiefenthaller, Heike Anders, Claus Belka, Kirsten Lauber · 2017 · Immunological Reviews
Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
Jing Ma, Mohanraj Ramachandran, Chuan Jin, Clara Quijano‐Rubio, Miika W. Martikainen, Di Yu, Magnus Essand · 2020 · Cell Death and Disease
Paclitaxel Induces Immunogenic Cell Death in Ovarian Cancer via TLR4/IKK2/SNARE-Dependent Exocytosis
Tat‐San Lau, Loucia Kit Ying Chan, Gene Chi Wai Man, Chi Hang Wong, Jacqueline Ho Sze Lee, So Fan Yim, Tak Hong Cheung, Iain A. McNeish, Joseph Kwong · 2020 · Cancer Immunology Research
Trial Watch
Lorenzo Galluzzi, Erika Vacchelli, Alexander M.M. Eggermont, Wolf H. Fridman, Jérôme Galon, Catherine Sautès‐Fridman, Éric Tartour, Laurence Zitvogel, Guido Kroemer · 2012 · OncoImmunology
Molecular Pathways: Involvement of Immune Pathways in the Therapeutic Response and Outcome in Breast Cancer
Fabrice André, Maria Vittoria Dieci, Peter Christian Dubsky, Christos P. Sotiriou, Giuseppe Curigliano, Carsten Denkert, Sherene Loi · 2012 · Clinical Cancer Research
Strange attractors: DAMPs and autophagy link tumor cell death and immunity
W Hou, Q Zhang, Z Yan, Renqiang Chen, Herbert J. Zeh, R Kang, Michael T. Lotze, Daolin Tang · 2013 · Cell Death and Disease
Chemotherapy and radiotherapy: Cryptic anticancer vaccines
Yuting Ma, Oliver Kepp, François Ghiringhelli, Lionel Apétoh, Laetitia Aymeric, Clara Locher, Antoine Tesnière, Isabelle Martins, André Ly, Nicole M. Haynes et al. · 2010 · Seminars in Immunology
Hydroxychloroquine in rheumatic autoimmune disorders and beyond
Eliise Laura Nirk, Fulvio Reggiori, Mario Mauthe · 2020 · EMBO Molecular Medicine
The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon
Robin J D Prestwich, Fiona Errington‐Mais, Rosa María Díaz, Hardev Pandha, Kevin Joseph Harrington, Alan A. Melcher, Richard G. Vile · 2009 · Human Gene Therapy
Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer
Dongqiang Zeng, Yunfang Yu, Qiyun Ou, Xiaoyin Li, Ru-Zhi Zhong, Chuanmiao Xie, Qiugen Hu · 2016 · Oncotarget
Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction
Guo‐Yun Chen, Xi Chen, Samantha King, Karen Angelica Cavassani, Jiansong Cheng, Xincheng Zheng, Hongzhi Cao, Hai Yu, Jingyao Qu, Dexing Fang et al. · 2011 · Nature Biotechnology
Chemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation
Qiaoshi Lian, Jun Xu, Shanshan Yan, Min Huang, Honghua Ding, Xiaoyu Sun, Aiwei Bi, Jian Ding, Bing Sun, Meiyu Geng · 2017 · Cell Research
Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity
NE Donlon, Robert F. Power, Conall Hayes, John Vincent Reynolds, Joanne Lysaght · 2021 · Cancer Letters
Measles virus causes immunogenic cell death in human melanoma
Oliver Donnelly, Fiona Errington‐Mais, Lynette P. Steele, Elizabeth M. Hadac, Victoria A. Jennings, Karen J. Scott, Howard Peach, Roger M. Phillips, Jacquelyn Bond, Hardev Pandha et al. · 2011 · Gene Therapy
The Role of Toll-Like Receptor in Inflammation and Tumor Immunity
Xiaohong Cen, Shuwen Liu, Kui Cheng · 2018 · Frontiers in Pharmacology
Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy
Colton John Ladbury, Chad G. Rusthoven, D. Ross Camidge, Brian D. Kavanagh, Sameer K. Nath · 2019 · International Journal of Radiation Oncology*Biology*Physics
Suppressing T cell motility induced by anti–CTLA-4 monotherapy improves antitumor effects
Maria Grazia Ruocco, Karsten A. Pilones, Noriko Kawashima, Michael Cammer, Julie H. Y. Huang, James S. Babb, Mengling Liu, Silvia Chiara Formenti, Michael Loran Dustin, Sandra Demaria · 2012 · Journal of Clinical Investigation
Cancer and Innate Immune System Interactions
Yanan Liu, Gang Zeng · 2012 · Journal of Immunotherapy
Molecular pathways and targets in cancer-related inflammation
Alberto Mantovani, Cecília Garlanda, Paola Allavena · 2010 · Annals of Medicine
Extracranial Oligometastases: A Subset of Metastases Curable With Stereotactic Radiotherapy
Kimberly S. Corbin, Samuel Hellmän, Ralph R. Weichselbaum · 2013 · Journal of Clinical Oncology
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy
Heng Yang, Yuting Ma, Guo Chen, Heng Zhou, Takahiro Yamazaki, Christophe Klein, Federico Pietrocola, Erika Vacchelli, Sylvie Souquère, Allan Sauvat et al. · 2016 · OncoImmunology
Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma
Joseph A. Califano, Zubair Hanif Khan, Kimberly Ann Noonan, Lakshmi Rudraraju, Zhe Zhang, Hao Wang, Steven N. Goodman, Christine Gail Gourin, Patrick K. Ha, Carole Fakhry et al. · 2015 · Clinical Cancer Research
Immunogenic cell death in cancer: concept and therapeutic implications
Lorenzo Galluzzi, Oliver Kepp, Erik C. Hett, Guido Kroemer, Francesco Maria Marincola · 2023 · Journal of Translational Medicine
Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance
Megha Budhwani, Roberta Mazzieri, Riccardo Dolcetti · 2018 · Frontiers in Oncology
VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC
Hailing Lu, Gregory N. Dietsch, Maura-Ann H. Matthews, Yi Yang, Smita Ghanekar, Margaret S. Inokuma, Maria A. Suni, Vernon C. Maino, Katherine E. Henderson, James Jeffry Howbert et al. · 2011 · Clinical Cancer Research
Immunomodulation by ionizing radiation—impact for design of radio‐immunotherapies and for treatment of inflammatory diseases
Benjamin Frey, Michael Rückert, Lisa Deloch, Paul F. Rühle, Anja Derer, Rainer Fietkau, Udo S. Gaipl · 2017 · Immunological Reviews
Tumor Microenvironment in Breast Cancer—Updates on Therapeutic Implications and Pathologic Assessment
Joshua Jing Xi Li, Julia Y. Tsang, Gary Man-Kit Tse · 2021 · Cancers
Complement Is a Central Mediator of Radiotherapy-Induced Tumor-Specific Immunity and Clinical Response
Laura Surace, Veronika Lysenko, Andrea Orlando Fontana, Virginia Cecconi, Hans Janssen, Antonela Bicvic, Michal J. Okoniewski, Martin N. Pruschy, Reinhard Dummer, Jacques Neefjes et al. · 2015 · Immunity
RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8+ T cells
Peter Duewell, A Steger, H Lohr, Hélène Bourhis, H Hoelz, Sabrina Viktoria Kirchleitner, Mareike R. Stieg, Simon A. Grassmann, Sebastian Kobold, Jens Thomas Siveke et al. · 2014 · Cell Death and Differentiation
Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis
Jayshree Mishra, Joseph Drummond, Sohel H. Quazi, Satya Sridhar Karanki, Jiajiu Shaw, Ben Chen, Narendra Kumar · 2012 · Critical Reviews in Oncology/Hematology
Immune Priming of the Tumor Microenvironment by Radiation
Wen Jiang, Charles K. F. Chan, Irving L. Weissman, Betty Y.S. Kim, Stephen M. Hahn · 2016 · Trends in cancer
Dendritic cell maturation in cancer
Chang Yoon Moon, Meriem Belabed, Matthew D. Park, Raphaël Mattiuz, Daniel J. Puleston, Miriam Mérad · 2025 · Nature reviews. Cancer
In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment
Claire Vanpouille‐Box, Karsten A. Pilones, Erik Wennerberg, Silvia Chiara Formenti, Sandra Demaria · 2015 · Vaccine
Immunological Mechanisms Underneath the Efficacy of Cancer Therapy
Galluzzi, Lorenzo, Zitvogel, Laurence, Kroemer, Guido · 2016 · Cancer Immunology Research
Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein
Le‐Xing Yu, Lei Yan, Wen K. Yang, Fuquan Wu, Ling Yan, Shuzhen Chen, Liang V. Tang, Yexiong Tan, Dan Cao, Mengchao Wu et al. · 2014 · Nature Communications
Role of T lymphocytes in tumor response to radiotherapy
Sandra Demaria, Silvia Chiara Formenti · 2012 · Frontiers in Oncology
The immune mechanisms of abscopal effect in radiation therapy
George Daniel Grass, Niveditha Krishna, Sungjune Kim · 2015 · Current Problems in Cancer
Cancer Stem Cell Immunology: Key to Understanding Tumorigenesis and Tumor Immune Escape?
Valentin S. Bruttel, Jöerg Wischhusen · 2014 · Frontiers in Immunology
Immunosenescence and cancer
Graham Pawelec, Evelyna Derhovanessian, Anis Larbi · 2010 · Critical Reviews in Oncology/Hematology
Necroptotic cell death in anti‐cancer therapy
Olga Krysko, Tania Løve Aaes, Valerian E. Kagan, Katharina G.M.A. D'Herde, Claus Bachert, Luc Leybaert, Peter Vandenabeele, Dmitri V. Krysko · 2017 · Immunological Reviews
Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade
Sachet Ashok Shukla, Pavan Bachireddy, Bastian Schilling, Christina Galonska, Qian Zhan, Clyde Bango, Rupert Langer, Patrick C. Lee, Daniel Gusenleitner, Derin B. Keskin et al. · 2018 · Cell
Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
Hiro Sato, Noriyuki Okonogi, Takashi Nakano · 2020 · International Journal of Clinical Oncology
Role of high mobility group box 1 in inflammatory disease: Focus on sepsis
Jong‐Sup Bae · 2012 · Archives of Pharmacal Research
Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy
Maxim Alekseevich Shevtsov, Hiro Sato, Gabriele Multhoff, Atsushi Shibata · 2019 · Frontiers in Oncology
The Abscopal Effect: A Review of Pre-Clinical and Clinical Advances
James Robert Janopaul-Naylor, Yang Shen, David C. Qian, Zachary S. Buchwald · 2021 · International Journal of Molecular Sciences
Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade
Leisha A. Emens · 2012 · Expert Review of Anticancer Therapy
Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer
Hangcheng Fu, Yu Zhu, Yiwei Wang, Zheng Liu, Junyu Zhang, Huyang Xie, Qiang Fu, Bo Dai, Dingwei Ye, Jiejie Xu · 2018 · Clinical Cancer Research
High hydrostatic pressure induces immunogenic cell death in human tumor cells
Jitka Palich Fucikova, Irena Kusova Moserova, Iva Truxová, Ivana Heřmanová, Irena Vančurová, Simona Partlová, Anna Fialová, Luděk Sojka, Pierre‐François Cartron, Milan Houška et al. · 2014 · International Journal of Cancer
De novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNA
Stephen M. Wiesner, Stacy A. Decker, Jon D. Larson, Katya Ericson, Colleen L. Forster, Jose L. Gallardo, Chunmei Long, Zachary L. Demorest, Edward A. Zamora, Walter C. Low et al. · 2009 · Cancer Research
Immunity, ageing and cancer
Derhovanessian, Evelyna, Solana, Rafael, Larbi, Anis, Pawelec, Graham · 2008 · Immunity & Ageing
Necroptosis‐Inducible Polymeric Nanobubbles for Enhanced Cancer Sonoimmunotherapy
Wooram Um, Hyewon Ko, Dong Gil You, Seungho Lim, Gijung Kwak, Man Kyu Shim, Suah Yang, Jeongjin Lee, Yeari Song, Kwangmeyung Kim et al. · 2020 · Advanced Materials
The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses
Tania Løve Aaes, Peter Vandenabeele · 2020 · Cell Death and Differentiation
Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity
Cédric Menard, François Martin, Lionel Apétoh, Florence Bouyer, François Ghiringhelli · 2008 · Cancer Immunology Immunotherapy
The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology
Steven Eric Finkelstein, Robert D Timmerman, William H. McBride, Dörthe Schaue, Sarah E. Hoffe, Constantine Anastasios Mantz, George David Wilson · 2011 · Clinical and Developmental Immunology
Combination immunotherapy approaches
Charles G. Drake · 2012 · Annals of Oncology
Effect of neoadjuvant chemotherapy on the immune microenvironment in non–small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches
Edwin Roger Parra, Pamela Andrea Villalobos, Carmen Behrens, Mei Jiang, Apar Pataer, Stephen G. Swisher, William N. William, Jiexin Zhang, Jack Lee, Tina Cascone et al. · 2018 · Journal for ImmunoTherapy of Cancer
The Role of Chronic Inflammation in the Development of Breast Cancer
David N. Danforth · 2021 · Cancers
Whole Cell Vaccines—Past Progress and Future Strategies
Bridget P. Keenan, Elizabeth M. Jaffee · 2012 · Seminars in Oncology
HMGB1: The Central Cytokine for All Lymphoid Cells
Guanqiao Li, Xiaoyan Liang, Michael T. Lotze · 2013 · Frontiers in Immunology
Toll-Like Receptor Agonists
Sacha Gnjatic, Nikhil B. Sawhney, Nina Bhardwaj · 2010 · The Cancer Journal
Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy
Jennifer Ann Wargo, Alexandre Reuben, Zachary Aaron Cooper, Kevin S. Oh, Ryan Joseph Sullivan · 2015 · Seminars in Oncology
Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer
Hirofumi Matsumoto, Aye Aye Thike, Huihua Li, Joe Poh-Sheng Yeong, Si‐Lin Koo, Rebecca Alexandra Dent, Puay Hoon Tan, Jabed Iqbal · 2016 · Breast Cancer Research and Treatment
An injectable hydrogel using an immunomodulating gelator for amplified tumor immunotherapy by blocking the arginase pathway
Xiaomeng Ren, Ningning Wang, Yaxin Zhou, Aixin Song, Guo‐Xia Jin, Zhonghao Li, Yuxia Luan · 2021 · Acta Biomaterialia
CAR-T cell combination therapy: the next revolution in cancer treatment
Maysoon T. Al-Haideri, Santalia Banne Tondok, Salar Hozhabri Safa, Ali Heidarnejad Maleki, Samaneh Miri Rostami, Abduladheem Turki Jalil, Moaed Emran Al-Gazally, Fahad Alsaikhan, Jasur Alimdjanovich Rizaev, Talar Ahmad Merza Mohammad et al. · 2022 · Cancer Cell International
Radiation as an Immune Modulator
Byron Burnette, Ralph R. Weichselbaum · 2013 · Seminars in Radiation Oncology
Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma
Noonan, Anne M, Farren, Matthew R, Geyer, Susan M, Huang, Ying, Tahiri, Sanaa, Ahn, Daniel, Mikhail, Sameh, Ciombor, Kristen K, Pant, Shubham, Aparo, Santiago et al. · 2016 · Molecular Therapy
Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy
Jiwoong Choi, Man Kyu Shim, Suah Yang, Hee Sook Hwang, Hanhee Cho, Jeongrae Kim, Wan Su Yun, Yujeong Moon, Jinseong Kim, Hong Yeol Yoon et al. · 2021 · ACS Nano
Pattern recognition receptors in the immune response against dying cells
Jeannin, Pascale, Jaillon, Sébastien, Delneste, Yves · 2008 · Current Opinion in Immunology
TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer
Sandeep Rajput, Lisa D. Volk-Draper, Sophia Ran · 2013 · Molecular Cancer Therapeutics
Transplantation and Damage-Associated Molecular Patterns (DAMPs)
Walter Gottlieb Land, Patrizia Agostinis, Stephan Gasser, Abhishek Dinkarnath Garg, Andreas Linkermann · 2016 · American Journal of Transplantation
Gut microbiome influences on anastomotic leak and recurrence rates following colorectal cancer surgery
Sara Gaines, Connie C Shao, Neil Hyman, John C. Alverdy · 2018 · British journal of surgery
Immune targets in the tumor microenvironment treated by radiotherapy
Omer M. Ozpiskin, Lu Zhang, Jian Jian Li · 2019 · Theranostics
Metronomic chemotherapy and immunotherapy in cancer treatment
Yu‐Li Chen, Ming-Cheng Chang, Wen‐Fang Cheng · 2017 · Cancer Letters
The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules
Kimberly M Arnold, Nicole J. Flynn, Adam Raben, Lindsay B. Romak, Yan Yu, Adam Paul Dicker, Firas Mourtada, Jennifer Sims‐Mourtada · 2018 · Cancer Growth and Metastasis
Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity
Claire Germain, Sacha Gnjatic, Marie‐Caroline Dieu‐Nosjean · 2015 · Frontiers in Immunology
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
Li-Chung Tsao, John S. Wang, Xingru Ma, Sirajbir S. Sodhi, Joey V. Ragusa, Bushangqing Liu, Jason McBane, Tao Wang, Jun-Ping Wei, Cong-Xiao Liu et al. · 2025 · Nature Communications
Leveraging the Immune System during Chemotherapy: Moving Calreticulin to the Cell Surface Converts Apoptotic Death from “Silent” to Immunogenic
Michel Obéid, Theocharis Panaretakis, Antoine Tesnière, Nick Joza, Roberta Tufi, Lionel Apétoh, François Ghiringhelli, Laurence Zitvogel, Guido Kroemer · 2007 · Cancer Research
Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer
Fucikova, Jitka, Moserova, Irena, Urbanova, Linda, Bezu, Lucillia, Kepp, Oliver, Cremer, Isabelle, Salek, Cyril, Strnad, Pavel, Kroemer, Guido, Galluzzi, Lorenzo et al. · 2015 · Frontiers in Immunology
Tumor cell lysates as immunogenic sources for cancer vaccine design
Fermín Eduardo González, María Alejandra Gleisner, Felipe Falcón-Beas, Fabiola Osorio, Mercedes Natalia López, Flavio Salazar‐Onfray · 2014 · Human Vaccines & Immunotherapeutics
Immunotherapy for Head and Neck Squamous Cell Carcinoma
Jessica M. Moskovitz, Jennifer D. Moy, Robert Louis Ferris · 2018 · Current Oncology Reports
Clinical development of immunotherapies for HER2+ breast cancer: a review of HER2-directed monoclonal antibodies and beyond
Ricardo Lima Barros Costa, Brian J. Czerniecki · 2020 · npj Breast Cancer